Breaking News Instant updates and real-time market news.

MYL

Mylan

$35.94

-0.9 (-2.44%)

08:16
10/10/16
10/10
08:16
10/10/16
08:16

Mylan settlement does not end EpiPen issue, says Wells Fargo

In a research note titled "Forget After Hrs. Quarterbacking - It is Not Back to Normal," Wells Fargo analyst David Maris says Mylan questions still remain after the company's lowered 2016 outlook and $465M Department of Justice settlement. One of Mylan's earnings levers, EpiPen pricing, is now off the table going forward, Maris tells investors in a research note. The analyst disagrees with investors that think the settlement puts the EpiPen pricing issue largely behind the company. The deal with the DOJ addresses only the Centers for Medicare and Medicaid Services portion of the issue, it does nothing to answer the original issue of EpiPen pricing and consumers, Maris contends. He points out that Mylan also disclosed in Friday's regulatory filing, but not in its press release, an SEC investigation by the Division of Enforcement. Maris says he's "not too excited" and doesn't gauge how good the news is by the after-hours share rally of 10%. He believes Mylan is "not back to normal" and keeps a Market Perform rating on the stock with a $43-$45 price target range. The shares are up 12% in pre-market trading to $40.35. Raymond James this morning upgraded Mylan to Strong Buy.

  • 09

    Nov

  • 28

    Mar

MYL Mylan
$35.94

-0.9 (-2.44%)

10/10/16
RAJA
10/10/16
UPGRADE
RAJA
Strong Buy
Mylan upgraded to Strong Buy from Market Perform at Raymond James
10/10/16
UBSW
10/10/16
NO CHANGE
Target $60
UBSW
Buy
UBS remains constructive on Mylan despite governance controversy
UBS analyst Marc Goodman said he remains constructive on Mylan despite the controversy surrounding its corporate governance. Goodman cited the company's ability to execute, its surprise announcement of a EpiPen Medicaid lawsuit settlement and its updated guidance, which was better than feared. Goodman reiterated his Buy rating and lowered his price target to $60 from $66 on Mylan shares.
10/10/16
RAJA
10/10/16
UPGRADE
Target $57
RAJA
Strong Buy
Mylan upgraded to Strong Buy on EpiPen settlement at Raymond James
As previously reported, Raymond James upgraded Mylan two notches to Strong Buy from Market Perform and established a $57 price target. Analyst Elliot WIlbur said the Department of Justice settlement over EpiPen rebates eliminates a significant overhang on shares enabling the focus to be back on fundamentals. With depressed absolute and relative valuation levels, Wilber sees favorable risk/reward scenarios even in a more tempered earnings growth environment.
10/10/16
JPMS
10/10/16
NO CHANGE
Target $52
JPMS
Overweight
Mylan settlement, updated guidance a positive, says JPMorgan
JPMorgan analyst Chris Schott views Mylan's $465M settlement with the Department of Justice relating to the potential misclassification of Epipen in the Medicaid Drug Rebate Program as well as its updated 2016 guidance as a positive. The news "removes litigation overhang at a reasonable cost and highlights the diversification of the base business and inexpensive valuation," Schott tells investors in a research note. He keeps an Overweight rating on Mylan with a $52 price target.

TODAY'S FREE FLY STORIES

UGAZ

VelocityShares 3x Long Natural Gas ETN

$82.04

5.36 (6.99%)

06:21
01/16/18
01/16
06:21
01/16/18
06:21
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTI

Ultimate Software

$226.28

-0.88 (-0.39%)

06:21
01/16/18
01/16
06:21
01/16/18
06:21
Recommendations
Ultimate Software analyst commentary  »

Ultimate Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 26

    Feb

AWK

American Water

$80.83

-3.91 (-4.61%)

06:21
01/16/18
01/16
06:21
01/16/18
06:21
Earnings
American Water affirms FY17 adjusted EPS view $3.00-$3.06, consensus $3.01 »

Updates FY17 GAAP EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$179.37

-8.4 (-4.47%)

06:21
01/16/18
01/16
06:21
01/16/18
06:21
Periodicals
Facebook VP says newsfeed changes will help users better connect, Wired reports »

Adam Mosseri, VP in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

EWZ

MSCI Brazil Index

$43.23

0.13 (0.30%)

06:20
01/16/18
01/16
06:20
01/16/18
06:20
Technical Analysis
MSCI Brazil Index: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFY

Infosys

$16.81

-0.46 (-2.66%)

06:20
01/16/18
01/16
06:20
01/16/18
06:20
Upgrade
Infosys rating change  »

Infosys upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$70.88

1.04 (1.49%)

, RDS.B

Royal Dutch Shell

$72.70

0.97 (1.35%)

06:19
01/16/18
01/16
06:19
01/16/18
06:19
Hot Stocks
Shell announces redevelopment of Penguins field in U.K.'s North Sea »

Royal Dutch Shell plc…

RDS.A

Royal Dutch Shell

$70.88

1.04 (1.49%)

RDS.B

Royal Dutch Shell

$72.70

0.97 (1.35%)

XOM

Exxon Mobil

$87.52

0.59 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFA

iShares MSCI EAFE Index Fund

$73.50

0.73 (1.00%)

06:19
01/16/18
01/16
06:19
01/16/18
06:19
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LECO

Lincoln Electric

$97.87

0.4 (0.41%)

06:19
01/16/18
01/16
06:19
01/16/18
06:19
Upgrade
Lincoln Electric rating change  »

Lincoln Electric upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFO

IHS Markit

$47.85

0.39 (0.82%)

06:19
01/16/18
01/16
06:19
01/16/18
06:19
Hot Stocks
IHS Markit sees FY18 CapEx approximately 6%-7% of revenue »

Sees FY18 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

JNK

SPDR Barclays High Yield Bond

$36.86

-0.06 (-0.16%)

06:18
01/16/18
01/16
06:18
01/16/18
06:18
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDRX

Allscripts

$16.03

0.09 (0.56%)

06:18
01/16/18
01/16
06:18
01/16/18
06:18
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

CERN

Cerner

$72.90

0.26 (0.36%)

06:18
01/16/18
01/16
06:18
01/16/18
06:18
Downgrade
Cerner rating change  »

Cerner downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

SJB

ProShares Short High Yield

$23.03

0.033 (0.14%)

06:18
01/16/18
01/16
06:18
01/16/18
06:18
Technical Analysis
ProShares Short High Yield: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRN

Ituran

$35.30

1.25 (3.67%)

06:18
01/16/18
01/16
06:18
01/16/18
06:18
Conference/Events
Ituran management to meet with Drexel Hamilton »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 17

    Jan

  • 17

    Jan

AN

AutoNation

$57.96

0.26 (0.45%)

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Hot Stocks
AutoNation sees benefit of about 80c-$1.10 per share in FY18 from tax reform »

AutoNation announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

HYG

iShares iBoxx $ High Yield Corporate Bond

$87.58

-0.15 (-0.17%)

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Technical Analysis
iShares iBoxx $ High Yield Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFO

IHS Markit

$47.85

0.39 (0.82%)

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Hot Stocks
IHS Markit CEO says 'very pleased with our fourth quarter' »

"We were very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

  • 16

    Jan

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$120.83

0.02 (0.02%)

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Technical Analysis
iShares iBoxx $ Investment Grade Corporate Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNR

Denbury Resources

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Upgrade
Denbury Resources rating change  »

Denbury Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTDR

Matador

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Upgrade
Matador rating change  »

Matador upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

CVS

CVS Health

$78.78

-0.24 (-0.30%)

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Hot Stocks
CVS Pharmacy pledges to end touchups of beauty images »

CVS Pharmacy, the retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SD

SandRidge Energy

$21.16

-0.12 (-0.56%)

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Downgrade
SandRidge Energy rating change  »

SandRidge Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLT

iShares 20+ Year Treasury Bond Fund

$124.52

0.21 (0.17%)

06:17
01/16/18
01/16
06:17
01/16/18
06:17
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$4.28

0.09 (2.15%)

06:16
01/16/18
01/16
06:16
01/16/18
06:16
Downgrade
Chesapeake rating change  »

Chesapeake downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.